Korea Otsuka Pharma’s Hyangnam Plant rises as a global hub
By Nho, Byung Chul | translator Alice Kang
21.10.12 16:13:56
가나다라
0
Established in 1989…. Produces and supplies 99% of the company’s pharmaceuticals released in Korea
Was selected as the first ever Digital Medicine (DM) manufacturing site in the world… reexport to Japan also raises attention
External growth of 40 billion a year in exports… is a cGMP·EU-GMP facility in charge of Norht America, EU and Asia-Pacific region
▲Pic. of Korea Otsuka Pharmaceutical
Korea Otsuka Pharmaceutical, which is soon to face its 40th anniversary in Korea, is receiving attention with its Hyangnam Plant rising as a forward base for global exports and production.Korea Otsuka Pharmaceutical is a global total healthcare enterprise that covers a wide range of businesses from clinical research, R&D, manufacturing, and export of pharmaceuticals. The company will celebrate its 40th anniversary in Korea in 2022.
It is one of the rare multinational pharmaceutical companies in Korea that owns and operates a large-scale production facility locally in the Hyangnam Pharmaceutical Industrial Complex in Gyeonggi-do.
99% of the company’s pharmaceutical produc
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)